Advanz Pharma
Present in over 90 countries worldwide, the company is committed to designing drugs neglected by the major pharmaceutical companies, ranging from endocrinology to pulmonary infections and hepatology.
Advanz Pharma is a market leader, successfully reaching niche targets on 4 continents. Advanz Pharma's expertise in the treatment of rare diseases is well established, and the company will have more than 300 pharmaceutical partners by 2023.
Advanz Pharma's aim is therefore to continue asserting its dominant position in the rare drugs market, but also to focus on innovation in order to broaden its spectrum of action and reach a wider audience.